The host of 'Good Morning Ghana' Randy Abbey has said that he hasn't seen people die for taking the covid-19 vaccine, but he has seen people die for not taking the vaccine so, he will prefer to take it.
Randy Abbey made this statement when he hosted 'Good Morning Ghana' today, 19th May 2021, and gave his opinion on the commencement of the second phase of vaccination today.
According to Randy Abbey, he was telling people who had problems with the vaccines that he has no problem with all the things they are reading about the covid-19 vaccines, but what he knows is that he has seen people die not taking the vaccine.
"I've not seen anybody die after taking the vaccine so, I will prefer to take the vaccine." - he said
He added that there are side effects that are known and we've all been told of so, he will urge people to go in for their second jab of the covid-19 vaccine, which begins today.
Content created and supplied by: Hope360 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More